ScholarLens Back to search
2009•Journal of Taishan Medical CollegeRequires access

Clinical value of CA15-3 in diagnosis and therapy of breast cancer

Qiang Chen

Open publisher page 0 citations

Abstract

Objective: To evaluate the clinical value of CA15-3 in diagnosis and therapy of breast cancer.Methods: Serum level of CA15-3 was detected by chemiluminescence immunoassay(CLIA) in 79 patients with breast cancer,30 patients with benign breast disease and 20 healthy adults.Results: Serum CA15-3 was significantly elevated in patients with breast cancer and differed significantly from that of control group and benign breast disease group;serum CA15-3 was significantly elevated in patients with stage Ⅲ、Ⅳ breast cancer;serum CA15-3 was significantly elevated in patients of matasases and relapse.Conclusion: CA15-3 is not proper marker of early diagnosis for breast cancer,but can be used to estimate the degree and prognosis of breast cancer,and be helpful to find matasases and relapse.

About this research paper

What this paper is about

Objective: To evaluate the clinical value of CA15-3 in diagnosis and therapy of breast cancer.Methods: Serum level of CA15-3 was detected by chemiluminescence immunoassay(CLIA) in 79 patients with breast cancer,30 patients with benign breast disease and 20 healthy adults.Results: Serum CA15-3 was significantly elevated in patients with breast cancer and differed significantly from that of control group and benign breast disease group;serum CA15-3 was significantly elevated in patients with stage Ⅲ、Ⅳ breast cancer;serum CA15-3 was significantly elevated in patients of matasases and relapse.Conclusion: CA15-3 is not proper marker of early diagnosis for breast cancer,but can be used to estimate the degree and prognosis of breast cancer,and be helpful to find matasases and relapse.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To evaluate the clinical value of CA15-3 in diagnosis and therapy of breast cancer.Methods: Serum level of CA15-3 was detected by chemiluminescence immunoassay(CLIA) in 79 patients with breast cancer,30 patients with benign breast disease and 20 healthy adults.Results: Serum CA15-3 was significantly elevated in patients with breast cancer and differed significantly from that of control group and benign breast disease group;serum CA15-3 was significantly elevated in patients with stage Ⅲ、Ⅳ breast cancer;serum CA15-3 was significantly elevated in patients of matasases and relapse.Conclusion: CA15-3 is not proper marker of early diagnosis for breast cancer,but can be used to estimate the degree and prognosis of breast cancer,and be helpful to find matasases and relapse.

Key concepts: Breast cancer, Medicine, CA15-3, Internal medicine, Oncology, Disease, Breast disease, Cancer

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Clinical value of CA15-3 in diagnosis and therapy of breast cancer — Research Paper | ScholarLens